Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Abstral 300 microgram sublingual tablets

Active Ingredient:
fentanyl citrate
Company:  
Grunenthal Meds See contact details
ATC code: 
N02AB03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Abstral - UK Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for healthcare professionals

{pdf_link}

Abstral - UK Patient and Carer guide

Important risk minimisation information, on Abstral (fentanyl citrate) sublingual tablet, for patients and their carers

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Grunenthal Meds
Company image
Address
Grünenthal Meds, Kyowa Kirin International UK NewCo Ltd, Building 6, Galabank Business Park, Galashiels, Borders, TD1 1QH, UK
WWW
www.grunenthalmedshub.co.uk
Telephone
+44 (0)1896 664 000
Fax
+44 (0)1896 664 001
Medical Information Direct Line
+44 (0)1896 664 000
Medical Information e-mail
[email protected]
Stock Availability
+44 (0)1896 664 000
Adverse event reporting email
[email protected]